Biomarkers and their applications for early diagnosis and/or recurrence monitoring of glioma
A biomarker and glioma technology, applied in the field of biomarkers for early diagnosis and/or recurrence monitoring of glioma, to achieve the effect of convenient and easy diagnosis, rapid and accurate diagnosis method, and high diagnostic value
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
1, the identification screening of molecular marker in cerebrospinal fluid exosome:
Through the above-mentioned whole transcriptome detection, it is found that only the expression amount of miRNA in the cerebrospinal fluid exosome is stable and reliable, and is not affected by
Preoperative and postoperative status, tumor and non-tumor, and interindividual differences were the best markers for CSF liquid biopsy (Fig.
2). The expression level of miRNA is the highest, and the difference between individuals is the smallest, and the overall expression level is the most stable
2. Only miRNA in cerebrospinal fluid exosomes can be used as liquid biopsy molecular marker for early diagnosis of glioma
By contrasting various cerebrospinal fluid exosome indexes such as miRNA, mRNA, lncRNA and circRNA, it was found that only
Some miRNAs can accurately distinguish the cerebrospinal fluid of tumor patients from normal control cerebrospinal fluid, while the rest of the RNA indicators c...
PUM
| Property | Measurement | Unit |
|---|---|---|
| diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 


